Response to Liposomal Doxorubicin and Clinical Outcome of HIV-1-Infected Patients with Kaposi's Sarcoma Receiving Highly Active Antiretroviral Therapy.
Nunez, M. MD 1; Saballs, P. MD 2; Valencia, M. E. MD 1; Santos, J. MD 3; Ferrer, E. MD 4; Santos, I. MD 5; Berrocal, A. MD 6; Galindo, M. J. MD 7; Podzamczer, D. MD 4; Gonzalez-Lahoz, J. MD 1; the CaelyxKS Spanish Study Group */
HIV Clinical Trials.
2(5):429-437, September/October 2001.
(Format: HTML, PDF)